Mental Health & the CB2 Receptor

[ad_1] In the first part of this series, we reviewed recent research into the role of the CB2 cannabinoid receptor in cancer proliferation. This week we turn our attention to another fascinating aspect of CB2 function: its impact on psychiatric and mood disorders despite not being concentrated in the central nervous system (CNS). After all, the CNS is the domain of its sibling, the CB1 cannabinoid receptor – the primary target of THC and the…

"Mental Health & the CB2 Receptor"

New Opinion Confirms Growing Trend Away from “Zero Tolerance” Cannabis Bankruptcy Relief Policy

[ad_1] As those in the cannabis industry are fully aware, the option of bankruptcy has not been available to cannabis or many cannabis-adjacent businesses to date. The courts have consistently indicated debtors who work in the cannabis industry or derive meaningful income from cannabis activity (directly or indirectly) cannot use bankruptcy, a federal mechanism, so long as marijuana remains illegal under federal law. The seminal Arenas decision from 2014 observed that things get especially awkward…

"New Opinion Confirms Growing Trend Away from “Zero Tolerance” Cannabis Bankruptcy Relief Policy"

Study: 1 in 10 US Veterans Used Cannabis in Past Year

[ad_1] While the United States has seen immense progress regarding cannabis law reform and reshaping the public opinion of the drug over the years, the continued lack of federal legalization and regulation is clear, especially in its effects on groups like veterans. Canada, which has legal cannabis throughout the country, introduced the Veterans Affairs Canada (VAC) reimbursement policy for medical cannabis, allowing reimbursement of up to three grams a day for qualified veterans. The VAC…

"Study: 1 in 10 US Veterans Used Cannabis in Past Year"

CBD Oil for Anxiety: What You Need to Know

[ad_1] The Potential of CBD Oil for Anxiety in America It’s no secret that anxiety has become a major problem in the United States today. According to the Anxiety and Depression Association of America, anxiety affects more than 40 million Americans age 18 and older. A 2018 poll from the American Psychiatric Association found that Americans feel more anxious today than previous years, with nearly two-thirds of Americans experiencing mild to severe anxiety related to…

"CBD Oil for Anxiety: What You Need to Know"

Will Medicare Ever Cover Medical Marijuana?

[ad_1]   Medical marijuana is becoming increasingly popular among older adults as a treatment for various conditions. However, despite its growing acceptance, uncertain safety standards, conflicting laws, and complex regulations could delay Medicare coverage for years.   In April 2022, the Medicare Plans Patient Resource Center conducted a survey showing that 20% of Medicare beneficiaries presently use medical marijuana, and nearly a quarter has used it before. The study revealed that 66% of the respondents…

"Will Medicare Ever Cover Medical Marijuana?"

Cannabis in a Capsule: Innovation at Work

[ad_1] Zelira Has Developed a Technology to Make Consistent Cannabinoid-Based Oral Medications a Reality. One of the most exciting aspects of covering the cannabis industry is the exponentially increasing innovation within the sector. In the medical field, studies are consistently being conducted to validate anecdotal evidence of the benefits cannabinoids offer. Manufacturers of cannabis accessories are using AI to more precisely weigh and distribute flower, and cultivators are using novel and increasingly sustainable technologies to…

"Cannabis in a Capsule: Innovation at Work"

Mechoulam on the Future of Cannabinoid Research

[ad_1] I was fortunate to cross paths with Raphael Mechoulam, “the father of cannabis research,” at several science conferences over the years. The most memorable occasion was the 22nd annual meeting of the International Cannabinoid Research Society (ICRS) in Freiburg, Germany, in July 2012. Mechoulam delivered a plenary speech at the symposium, addressing the future of cannabinoid research and key areas of study that should be pursued. It was exactly fifty years earlier, in 1962,…

"Mechoulam on the Future of Cannabinoid Research"

Cocaine Trade Open in Canada? Not So Fast

[ad_1] In the U.S., cocaine is a Schedule II controlled substance and its use, possession, etc. is illegal except for certain, limited medical applications. The licensed sale of cocaine for recreational use is not even remotely a concept in the U.S., and the same goes for Canada. Why then did we see a Canadian cannabis company announce that it had the ability to make and sell cocaine to the consumer public? Essentially because of a…

"Cocaine Trade Open in Canada? Not So Fast"

‘Father of Cannabis Science’ Raphael Mechoulam Dead at 92

[ad_1] Raphael Mechoulam, the first person to synthesize THC, earning him the moniker the “Father of Cannabis Science,” has died, Analytical Cannabis reports. He was 92 years old, and his legacy will most certainly live on for centuries to come. The esteemed chemist is also called the father of cannabis research. Some of his additional game-changing contributions to drug science include isolating and synthesizing other cannabinoids, such as cannabidiol (CBD), cannabigerol (CBG), and cannabichromene (CBC). …

"‘Father of Cannabis Science’ Raphael Mechoulam Dead at 92"

The Benefits of Using CBD Oil for Epilepsy

[ad_1] The Benefits of Using CBD Oil for Epilepsy by Aaron Cadena at CBD Origin CBD Oil for Epilepsy CBD is the non-psychoactive counterpart of the hemp plant. According to a 2013 study published in the British Journal of Clinical Pharmacology, CBD provides a wide variety of benefits due to its anti-inflammatory, anticonvulsant, antioxidant, antiemetic, and anxiolytic properties. These properties have allowed CBD to provide significant relief for people suffering from ailments such as anxiety,…

"The Benefits of Using CBD Oil for Epilepsy"